Related Experiment Video
Updated: Jun 19, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
ANTIBODY AND AGGLUTININ IN PNEUMOCOCCUS PNEUMONIA
1Medical Laboratory and Services of the Massachusetts General Hospital, Boston.
Abstract:
1. Protective substances and agglutinins were not demonstrated in the blood of patients with pneumonia untreated with serum before the fall in the temperature by crisis or lysis. 2. Protective substances and agglutinins were frequently demonstrated in serum treated patients during the course of the disease. 3. Protective substances and agglutinins were usually present at the time of the temperature fall in patients untreated with serum and persisted for days or weeks thereafter. 4. Protective substances have an important bearing on the outcome. A large proportion of those with protection recover and a large proportion without it die. 5. Agglutinin and antibody may appear simultaneously or one may precede or be present without the other. 6. Tests for agglutinin are unreliable as a control of dosage of specific serum.
Related Concept Videos
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...

